Arlene Naranjo
Arlene Naranjo
Research Assistant Professor of Biostatistics, University of Florida
Verified email at ufl.edu
Title
Cited by
Cited by
Year
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
TF Eleveld, DA Oldridge, V Bernard, J Koster, LC Daage, SJ Diskin, ...
Nature genetics 47 (8), 864-871, 2015
3422015
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study
J Vermeulen, K De Preter, A Naranjo, L Vercruysse, N Van Roy, ...
The lancet oncology 10 (7), 663-671, 2009
1822009
Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children’s oncology group
GA Yanik, MT Parisi, BL Shulkin, A Naranjo, SG Kreissman, WB London, ...
Journal of nuclear medicine 54 (4), 541-548, 2013
1432013
A prospective study of expectant observation as primary therapy for neuroblastoma in young infants, a children’s oncology group study
JG Nuchtern, WB London, CE Barnewolt, A Naranjo, PW McGrady, ...
Annals of surgery 256 (4), 573, 2012
1422012
Irinotecan–temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial
R Mody, A Naranjo, C Van Ryn, LY Alice, WB London, BL Shulkin, ...
The lancet oncology 18 (7), 946-957, 2017
1272017
Children's Oncology Group's 2013 blueprint for research: renal tumors
JS Dome, CV Fernandez, EA Mullen, JA Kalapurakal, JI Geller, V Huff, ...
Pediatric blood & cancer 60 (6), 994-1000, 2013
1222013
High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk
EV Barnes, S Narain, A Naranjo, J Shuster, MS Segal, ES Sobel, ...
Lupus 14 (8), 576-582, 2005
1222005
Pilot induction regimen incorporating pharmacokinetically guided topotecan for treatment of newly diagnosed high-risk neuroblastoma: a Children's Oncology Group study
JR Park, JR Scott, CF Stewart, WB London, A Naranjo, VM Santana, ...
Journal of clinical oncology 29 (33), 4351, 2011
1112011
Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children’s Oncology Group study
LL Wang, R Teshiba, N Ikegaki, XX Tang, A Naranjo, WB London, ...
British journal of cancer 113 (1), 57-63, 2015
892015
Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's …
JG Villablanca, WB London, A Naranjo, P McGrady, MM Ames, JM Reid, ...
Clinical Cancer Research 17 (21), 6858-6866, 2011
882011
miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples
K De Preter, P Mestdagh, J Vermeulen, F Zeka, A Naranjo, I Bray, ...
Clinical Cancer Research 17 (24), 7684-7692, 2011
862011
Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG
C Okamatsu, WB London, A Naranjo, MD Hogarty, JM Gastier‐Foster, ...
Pediatric blood & cancer 53 (4), 563-569, 2009
782009
Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group
K Campbell, JM Gastier‐Foster, M Mann, AH Naranjo, C Van Ryn, ...
Cancer 123 (21), 4224-4235, 2017
722017
Effect of tandem autologous stem cell transplant vs single transplant on event-free survival in patients with high-risk neuroblastoma: a randomized clinical trial
JR Park, SG Kreissman, WB London, A Naranjo, SL Cohn, MD Hogarty, ...
Jama 322 (8), 746-755, 2019
692019
Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2
JI Geller, PF Ehrlich, NG Cost, G Khanna, EA Mullen, EJ Gratias, ...
Cancer 121 (14), 2457-2464, 2015
682015
A phase III randomized clinical trial (RCT) of tandem myeloablative autologous stem cell transplant (ASCT) using peripheral blood stem cell (PBSC) as consolidation therapy for …
JR Park, SG Kreissman, WB London, A Naranjo, SL Cohn, MD Hogarty, ...
Journal of clinical oncology 34 (18_suppl), LBA3-LBA3, 2016
652016
A genome-wide association study identifies susceptibility loci for Wilms tumor
C Turnbull, ER Perdeaux, D Pernet, A Naranjo, A Renwick, S Seal, ...
Nature genetics 44 (6), 681-684, 2012
652012
A genome-wide association study identifies susceptibility loci for Wilms tumor
C Turnbull, ER Perdeaux, D Pernet, A Naranjo, A Renwick, S Seal, ...
Nature genetics 44 (6), 681-684, 2012
652012
A genome-wide association study identifies susceptibility loci for Wilms tumor
C Turnbull, ER Perdeaux, D Pernet, A Naranjo, A Renwick, S Seal, ...
Nature genetics 44 (6), 681-684, 2012
652012
Reducing developmental risk for emotional/behavioral problems: A randomized controlled trial examining the Tools for Getting Along curriculum
AP Daunic, SW Smith, CW Garvan, BR Barber, MK Becker, CD Peters, ...
Journal of School Psychology 50 (2), 149-166, 2012
632012
The system can't perform the operation now. Try again later.
Articles 1–20